This site uses cookies and by using the site you are consenting to this. Find out what cookies are, why we use them and how to manage your settings in our cookie policy.

Changing your cookie settings

All browsers provide tools that allow you to control how they handle cookies: accept, reject or delete them. These settings are normally accessed via the 'preferences' or 'options' menu of the browser you are using. Read more...

Cookies Close

Conformetrix

A new dimension in drug discovery

Home

Board Members

Chief Scientific Officer and Co-Founder: Charles Blundell, DPhil

Charles is co-inventor of Conformetrix's core technology and a renowned NMR biologist with over 10 years of structural biology expertise. He has a degree and DPhil in Biochemistry from the University of Oxford, where he worked under Professor Iain Campbell FRS, followed by post-doctoral research there before moving to the University of Manchester. Charles has published extensively in peer-reviewed publications.

More in this category: « Chief Technical Officer and Co-Founder: Andrew Almond, PhD Non-Executive Director: Harry Finch, PhD »